Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida G Lunde

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Journal of Molecular and Cellular Cardiology|November 27, 2012
Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stressKate M Herum, Ida G Lunde, Biljana Skrbic, et al.
Cardiology|January 23, 2020
Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure OverloadNaiyereh Mohammadzadeh, Arne Olav Melleby, Sheryl Palmero, et al.
Physiological Genomics|December 1, 2011
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failureIda G Lunde, Jan Magnus Aronsen, Heidi Kvaløy, et al.
Frontiers in Cardiovascular Medicine|March 16, 2026
Association between neutrophil extracellular traps, the Von Willebrand factor axis, and clinical outcome in stable coronary artery diseaseVibeke Bratseth, Kristine M Kindberg, Ellen M K Warlo, et al.
Plos One|October 22, 2016
The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 SignalingArne O Melleby, Mari E Strand, Andreas Romaine, et al.
Plos One|July 28, 2018
The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodelingKine Andenæs, Ida G Lunde, Naiyereh Mohammadzadeh, et al.
Molecular Biology Reports|October 7, 2022
Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophyIda G Lunde, J Magnus Aronsen, A Olav Melleby, et al.
Biomedicines|May 16, 2023
Inflammation and Syndecan-4 Shedding from Cardiac Cells in Ischemic and Non-Ischemic Heart DiseaseMari E Strand, Maarten Vanhaverbeke, Michiel T H M Henkens, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 6, 2022
Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heartAndreas Romaine, Arne Olav Melleby, Jahedul Alam, et al.
The Journal of Experimental Biology|May 7, 2017
Bigger is not better: cortisol-induced cardiac growth and dysfunction in salmonidsIda B Johansen, Erik Sandblom, Peter V Skov, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Molecular and Cellular Cardiology|November 27, 2012
Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stressKate M Herum, Ida G Lunde, Biljana Skrbic, et al.
Cardiology|January 23, 2020
Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure OverloadNaiyereh Mohammadzadeh, Arne Olav Melleby, Sheryl Palmero, et al.
Physiological Genomics|December 1, 2011
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failureIda G Lunde, Jan Magnus Aronsen, Heidi Kvaløy, et al.
Frontiers in Cardiovascular Medicine|March 16, 2026
Association between neutrophil extracellular traps, the Von Willebrand factor axis, and clinical outcome in stable coronary artery diseaseVibeke Bratseth, Kristine M Kindberg, Ellen M K Warlo, et al.
Plos One|October 22, 2016
The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 SignalingArne O Melleby, Mari E Strand, Andreas Romaine, et al.
Plos One|July 28, 2018
The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodelingKine Andenæs, Ida G Lunde, Naiyereh Mohammadzadeh, et al.
Molecular Biology Reports|October 7, 2022
Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophyIda G Lunde, J Magnus Aronsen, A Olav Melleby, et al.
Biomedicines|May 16, 2023
Inflammation and Syndecan-4 Shedding from Cardiac Cells in Ischemic and Non-Ischemic Heart DiseaseMari E Strand, Maarten Vanhaverbeke, Michiel T H M Henkens, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 6, 2022
Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heartAndreas Romaine, Arne Olav Melleby, Jahedul Alam, et al.
The Journal of Experimental Biology|May 7, 2017
Bigger is not better: cortisol-induced cardiac growth and dysfunction in salmonidsIda B Johansen, Erik Sandblom, Peter V Skov, et al.
Pageof 6